Safe Use of Butorphanol–Azaperone–Medetomidine to Immobilize Free‐Ranging White‐tailed Deer

Patterns of white-tailed deer movements in suburban Maryland: implications for zoonotic disease mitigation

Understanding the ecology of the often dense white-tailed deer populations in urban and suburban landscapes is important for mitigating a variety of conflicts that arise with dense human populations, such as issues surrounding zoonotic disease mitigation. We collared white-tailed deer in highly suburban areas of Howard County, Maryland with high-resolution GPS collars. Then, we created autocorrelated kernel density home ranges for broader land use analyses and concurrently used general additive models to characterize fine-scale hourly measures of speed, activity, and proximity to residential buildings. Suburban deer home ranges encompassed approximately 35% direct residential land, and an average of 71 and 129 residential properties were found within female and male core ranges, respectively. Sex, time of day, and day of year all influenced fine-scale speeds, activity levels, and proximity to residential property buildings. Deer moved into residential areas nightly, especially in winter, and exhibited bouts of increased speed and activity shortly after sunrise and sunset, with distinctive seasonal changes. We discuss how variation in home ranges and movements may influence population management success and explore year-round periods of increased risk of deer transporting ticks to residential areas. These findings focus our broad understanding of deer movements in suburban and urban landscapes to improve deer population management and to mitigate the spread of ticks into residential areas.

BUTORPHANOL, AZAPERONE, AND MEDETOMIDINE ANESTHESIA IN FREE-RANGING EASTERN MOOSE (ALCES AMERICANUS)

Fifty-three free-ranging moose (Alces americanus) cows were darted from a helicopter with 3-4 ml of a premix combination of butorphanol (27.3 mg/ml), azaperone (9.1 mg/ml), and medetomidine (10.9 mg/ml; BAM), equivalent to estimated dosages of: butorphanol 0.26 ± 0.08 (mean ± SD) mg/kg, azaperone 0.09 ± 0.03 mg/kg, and medetomidine 0.11 ± 0.03 mg/kg. After a mean chase time (from sighting to darting) of 6.1 ± 5.5 min, the mean induction time (from darting to recumbency) was 8.3 ± 2.6 min. This combination provided a safe and reliable sedation for minor procedures that lasted 30-60 min. Heart rate (50.4 ± 7.0 beats/min), respiratory rate (21.3 ± 11.1 breaths/minute), ETCO₂ via nasal canula (43.2 ± 7.0 mmHg), and rectal temperature (38.5°C ± 0.7°C) mostly remained at expected values for wild cervid and bovid species anesthetized with this drug combination. SpO₂ (90.0% ± 3.7%) was suggestive of moderate hypoxemia despite intranasal oxygen supplementation (1 L per 100 kg/min). The recovery time to standing was 6.7 ± 3.8 min after reversal with IM naltrexone (3 mg/mg butorphanol) and atipamezole (5 mg/mg medetomidine). Despite a larger volume to inject, this protocol offers an alternative to highly potent opioids, and should be considered for practical or staff safety reasons. On the basis of the results of this study, the use of 4 ml of BAM is considered a safe and effective protocol for immobilization of cow moose under comparable settings.